Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers C > Headlines for Calendar > News item |
Convertibles Calendar
OCTOBER
REGENERON PHARMACEUTICALS INC. (Nasdaq: REGN): $400 million convertible senior notes due 2016; $60 million over-allotment option; Rule 144A offering; proceeds to cover cost of convertible note hedge transactions and for general corporate purposes; Tarrytown, N.Y.-based biopharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.